Search Prime Grants

U54CA272205

Cooperative Agreement

Overview

Grant Description
University of Maryland First Program
Awardee
University Of Maryland, Baltimore
Funding Goals
TO PROVIDE AN ORGANIZATIONAL FOCUS AND STIMULUS FOR THE HIGHEST QUALITY CANCER RESEARCH THAT EFFECTIVELY PROMOTES INTERDISCIPLINARY CANCER RESEARCH AIMED TOWARD THE ULTIMATE GOAL OF REDUCING CANCER INCIDENCE, MORTALITY AND MORBIDITY. THE CANCER CENTER SUPPORT GRANT (CCSG) PROVIDES THE RESOURCES AND INFRASTRUCTURE TO FACILITATE THE COORDINATION OF INTERDISCIPLINARY PROGRAMS ACROSS A BROAD SPECTRUM OF RESEARCH FROM BASIC LABORATORY RESEARCH TO CLINICAL INVESTIGATION TO POPULATION SCIENCE. THE CCSG SUPPORTS SALARIES FOR SCIENTIFIC LEADERSHIP OF THE CENTER, SHARED RESOURCES FOR FUNDED CENTER INVESTIGATORS, CERTAIN ADMINISTRATIVE COSTS, PLANNING AND EVALUATION, AND DEVELOPMENTAL FUNDS FOR NEW RECRUITMENTS AND FEASIBILITY STUDIES.
Grant Program (CFDA)
93.310 - Trans-NIH Research Support
Awarding Agency
National Cancer Institute (NCI) [HHS - NIH]
Funding Agency
National Institute of Allergy and Infectious Diseases (NIAID) [HHS - NIH]
Place of Performance
Baltimore, Maryland 21201 United States
Geographic Scope
Single Zip Code
Related Opportunity
NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) (RFA-RM-21-025)
Analysis Notes
Amendment Since initial award the total obligations have increased 2153% from $394,485 to $8,886,100.
University Of Maryland, Baltimore was awarded University of Maryland FIRST Program Cooperative Agreement U54CA272205 worth $8,886,100 from the National Institute of Allergy and Infectious Diseases in September 2022 with work to be completed primarily in Baltimore Maryland United States. The grant has a duration of 5 years and was awarded through assistance program 93.310 Trans-NIH Research Support. The Cooperative Agreement was awarded through grant opportunity NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional).

Status
(Ongoing)

Last Modified 7/21/25

Period of Performance
9/9/22
Start Date
8/31/27
End Date
59.0% Complete

Funding Split
$8.9M
Federal Obligation
$0.0
Non-Federal Obligation
$8.9M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U54CA272205

Subgrant Awards

Disclosed subgrants for U54CA272205

Transaction History

Modifications to U54CA272205

Additional Detail

Award ID FAIN
U54CA272205
SAI Number
U54CA272205-4083260027
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH National Cancer Institute
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
Z9CRZKD42ZT1
Awardee CAGE
1B0S2
Performance District
MD-07
Senators
Benjamin Cardin
Chris Van Hollen

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Office of the Director, National Institutes of Health, Health and Human Services (075-0846) Health research and training Grants, subsidies, and contributions (41.0) $4,495,830 100%
Modified: 7/21/25